Insider Transactions Reported by 18 Insiders of Aprea Therapeutics, Inc.

Symbol
APRE on Nasdaq
Location
Doylestown, PA

Insiders trading volume in the past year

Aprea Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
CHRISTIAN S. SCHADE Director $976,345 28 Jul 2022
Scott M. Coiante SVP, Chief Financial Officer $533,970 28 Jul 2022
Oren Gilad President/CEO, Director $359,265 +$60,119 +20% 30 Jan 2026
Marc Duey Director $299,226 +$25,000 +9.1% 10 Dec 2025
Eyal C. Attar SVP, Chief Medical Officer, Director $211,254 03 Jun 2022
Gregory Alan Korbel SVP, Chief Operating Officer $168,445 28 Jul 2022
Lars B. Abrahmsen SVP, Chief Scientific Officer $160,855 10 Mar 2022
Bernd R. Seizinger Director $74,155 05 Jun 2025
Nadeem Q. Mirza Chief Medical Officer $49,062 01 May 2024
Rifat Pamukcu Director $31,676 05 Jun 2025
John P. Hamill SrVP/CFO/Prin Fin & Acct Ofcr $29,755 +$10,898 +58% 30 Jan 2026
Michael Aaron Kelly Director $16,969 30 Jun 2021
Fouad Namouni Director $16,969 30 Jun 2021
John B. Henneman III Director $16,570 05 Jun 2025
Richard Peters Director $5,052 05 Jun 2025
Michael Grissinger Director $4,680 05 Jun 2025
Gabriela Gruia Director $1,692 05 Jun 2025
JEAN-PIERRE BIZZARI Director $1,692 05 Jun 2025

Recent Insider Transactions by Companies or Individuals for Aprea Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.